The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Will Be The Estimated Market Size Of The Pharmaceutical Excipients Market By 2030?
The pharmaceutical excipients market has experienced substantial growth in recent years. It is projected to expand from $10822.05 billion in 2025 to $11529.87 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.5%. This historic growth is largely attributable to factors such as increasing demand for oral formulations, expanding pharmaceutical manufacturing in APAC, the adoption of synthetic excipients, stringent regulatory approvals, and a rise in research and development within drug formulation.
The pharmaceutical excipients market is projected to experience robust expansion over the coming years. It is anticipated to reach $14867 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.6%. This projected growth can be attributed to several factors, including the increasing adoption of personalized medicine, a surge in biopharmaceutical production, rising demand for natural and clean-label excipients, advancements in excipient synthesis technology, and the expansion of contract manufacturing organizations (CMOs). Prominent trends during this forecast period are expected to include novel excipient formulations, enhanced drug stability solutions, targeted drug delivery systems, the use of natural and plant-based excipients, and the development of multi-functional excipients.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3415&type=smp
What Major Growth Factors Are Impacting The Pharmaceutical Excipients Market?
The escalating sales of biologics are anticipated to stimulate growth in the pharmaceutical sterility testing market. Biologics, also known as biological products, are therapeutic agents derived from living organisms, including various items like vaccines, blood and its components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Pharmaceutical excipients are essential in biologics, serving to enhance stability, refine formulation, and ensure optimal delivery of the active biological agents. For example, in October 2024, the Generics and Biosimilars Initiative, a Belgium-based organization that provides high-quality, scientific information on generic and biosimilar medicines, reported that alongside the nine leading biologics, two additional complex drugs achieved significant sales in 2023. These included Novo Nordisk’s Ozempic (semaglutide) and Eli Lilly’s Trulicity (dulaglutide), both prescribed for type 2 diabetes, which generated sales of US$14 billion and US$7.2 billion, respectively. This demonstrates how the increase in biologics sales is a significant driver for the pharmaceutical excipients market.
What Are The Major Segment Categories Within The Pharmaceutical Excipients Market?
The pharmaceutical excipients market covered in this report is segmented –
1) By Product: Inorganic Chemicals, Organic Chemicals, Other Products
2) By Functionality: Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities
3) By Type Of Formulation: Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations
Subsegments:
1) By Inorganic Chemicals: Salts, Oxides, Silicates
2) By Organic Chemicals: Sugars, Polymers, Oils And Fats
3) By Other Products: Natural Excipients, Coatings, Antioxidants
What Trends Are Influencing The Pharmaceutical Excipients Market?
Major companies operating in the pharmaceutical excipient market are actively launching advanced excipients, including high-purity excipients, to improve drug formulation stability, boost bioavailability, and facilitate complex drug delivery systems. High-purity excipients are characterized as pharmaceutical excipients that have undergone sophisticated purification processes to remove impurities and contaminants. As an illustration, in October 2023, Clariant, a Switzerland-based specialty chemical company, introduced three new VitiPure excipients, specifically engineered to enhance the stability and solubility of active pharmaceutical ingredients (APIs). These offerings consist of VitiPure O 80 Superior, a high-purity polysorbate 80; VitiPure CO 35 Superior, a polyoxyl 35 castor oil; and VitiPure Meglumine LEX, which is a solubilizer with low bioburden. Designed for various drug delivery applications, particularly sensitive formulations such as mRNA vaccines and biologics, these excipients address the growing need for high-purity ingredients while adhering to strict regulatory standards.
Who Are The Prominent Players Across The Pharmaceutical Excipients Market?
Major companies operating in the pharmaceutical excipients market are BASF SE, Ashland Global Holdings, Evonik Industries AG, International Flavors & Fragrances Inc, Roquette Frères, Archer Daniels Midland Company, Lubrizol Corporation, Croda International Plc, Kerry Group, DuPont de Nemours Inc., Amster Microcell Private Limited, Finar Limited, P. D. Polychem Private Limited, CAD Pharma Inc, Maas Pharma Chemicals, Aeon Procare Private Limited, CSPC Pharmaceutical Group Ltd, Allen & Hanburys Ltd, Colorcon, MEGGLE GmbH & Co. KG, DMV-Fonterra Excipients GmbH & Co. KG, Alpen Pharma AG, Avantor Inc, JRS PHARMA GmbH & Co. KG, The Dow Chemical Co, EMS Pharma, Biolab Farmaceutica, Medist FZE, W.R. Grace, Univar Solutions, Nitika Pharma, DFE Pharma, Cargill, Sensient Pharma
Access The Complete Pharmaceutical Excipients Market Report:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report
Which Region Accounts For The Highest Share Of The Pharmaceutical Excipients Market?
North America is the largest region in the pharmaceutical excipients market in 2025. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market share during the forecast period. The regions covered in the pharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Pharmaceutical Excipients Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=3415&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Excipients Market 2026, By The Business Research Company
Pharmaceutical Excipient Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report
Organic Pharmaceutical Excipients Market Report 2026
Alcohol Excipients Market Report 2026
https://www.thebusinessresearchcompany.com/report/alcohol-excipients-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model